DGAP-News: Asklepios Clinics treat more patients in 2012. Investments in the quality of medical care

DGAP-News: Asklepios Clinics treat more patients in 2012. Investments in the quality of medical care

ID: 254160

(firmenpresse) - DGAP-News: Asklepios Kliniken GmbH / Key word(s): Final Results
Asklepios Clinics treat more patients in 2012. Investments in the
quality of medical care

30.04.2013 / 08:30

---------------------------------------------------------------------

Hamburg, 30th April 2013. Asklepios has expanded its activities in the
German healthcare market and was able to increase sales and earnings in the
fiscal year 2012. Thus, the hospitals could increase the number of patients
by 14.7 per cent compared to the previous year to almost two million.

Sales increased by 16.5 per cent to 3.0bn Euro (previous year: 2.6bn Euro).
Particularly the newly acquired MediClin AG hospitals had a full-year
effect here for the first time. The organic growth in the amount of 3.5 per
cent was achieved through new medical services, occupancy management and
performance-based compensation agreements.

Despite the nationwide trend of increasing wage settlements as well as the
continuing high price pressure due to supererogation reductions for general
hospital services, the operative result before interest, taxes,
depreciation, amortisation and rent (EBITDAR) increased by 33.5 per cent to
322.9m Euro (previous year: 241.8m Euro) in particular due to the
first-time full-year consideration of MediClin AG. The corresponding
operating margin increased by 1.3 percentage points to 10.8 per cent. 'In
our view, the increase of the margin is positive especially with the
background of the general market conditions as well as some operational
challenges and the related restructuring required,' says Stephan Leonhard,
Vice Chairman of Corporate Management and CFO.

The result before interest and taxes (EBIT) amounted to 163.8m Euro with a
margin of 5.5 per cent (previous year: 134.2m Euro, 5.2 per cent). The
consolidated net income for the year improved from 35.7m Euro (excluding




special effects, the consolidated net income was at 87.0m Euro) in 2011 to
112.9m Euro in the fiscal year 2012. The return on sales in the fiscal year
2012 amounted to 3.8 per cent.

Solid balance sheet and financing structure; equity ratio 32.2 per cent

The Asklepios Group generated a net cash flow of 225.5m Euro in 2012; a
substantial part thereof will be used for investments in stocks as well as
debt repayments. At the close of the fiscal year 2012, the net debt
amounted to 624.5m Euro, of which 118.4m Euro was allotted to subordinated
debt. The leverage ratio thus lies at 2.3 times the EBITDA.
At the end of the fiscal year 2012, the Group maintained a solid financial
structure with an equity ratio of 32.2 per cent. The Asklepios Group had
liquid assets in the amount of 145.9m Euro as well as unused credit lines
of more than 209m Euro available to carry out future investments especially
regarding the quality of medical care.?The Asklepios Group has further potential within the Group structure

In the past fiscal year, Asklepios was able to achieve the first successes
in the integration of MediClin AG into the Asklepios Group. An
establishment of common regional structures could already generate added
value.
'The Group structure also offers our employees and facilities opportunities
that are not possible in smaller structures', says Dr. Ulrich
Wandschneider, Chairman of Corporate Management and emphasizes: 'We will
utilise these opportunities even more in terms of our efficiency programme
nextStep so that we continue to meet the increasing demand for medical
services at the highest level.'

Outlook

The legal environment has not improved in 2013 compared to the previous
year - the demanding economic challenges still pertain for the whole
industry given the continuously increasing costs. Asklepios therefore
continues to focus on the topics of quality, efficiency (e.g. through
standardisation) and cost optimisation group-wide. Many activities and
individual measures are consolidated in the efficiency programme
'nextStep'. The associated investment and restructuring programmes have a
high priority and are being swiftly implemented. With these targeted
activities Asklepios ensures continued organic growth. External growth will
only be generated by the acquisition of facilities as long as these fit
into the Group structure regionally and strategically, and show
corresponding revenue potential.

---

The healthcare group Asklepios Clinics GmbH ranks among the three largest
private operators of hospitals and healthcare facilities in Germany. The
clinic group follows a sustainable growth strategy based on responsibility,
high quality and innovative strength. Based on this, Asklepios has been
rewarded with dynamic growth since its founding more than 25 years ago.
Currently the group has more than 140 healthcare facilities and employs
more than 45,000 employees throughout Germany. During the last business
year 2012, Asklepios treated about 2 m. patients at Asklepios Group
facilities.

Contact for media representatives:

Thomas Pfaadt
Head of Corporate Finance&Investor Relations
Tel.: +49 6174 90-1192 - Fax: +49 6174 90-1110
t.pfaadt(at)asklepios.com; www.asklepios.com/ir

Rudi Schmidt
Head of Corporate Communication&Marketing
Tel.: +49 (040) 18 18-82 66 30 - Fax: +49 (040) 18 18-82 66 39
24 hour on-call service press office: +49 (040) 18 18-82 88 88
presse(at)asklepios.com; www.asklepios.com

Asklepios on web, facebook or YouTube:
www.asklepios.com;
www.facebook.com/asklepioskliniken;
www.youtube.com/asklepioskliniken


End of Corporate News

---------------------------------------------------------------------

30.04.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


209060 30.04.2013


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  DGAP-News: EnviTec Biogas remains profitable in challenging year 2012 A Dive Into Good Physical, Mental Health
Bereitgestellt von Benutzer: EquityStory
Datum: 30.04.2013 - 08:30 Uhr
Sprache: Deutsch
News-ID 254160
Anzahl Zeichen: 7352

contact information:

Kategorie:

Business News



Diese Pressemitteilung wurde bisher 328 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"DGAP-News: Asklepios Clinics treat more patients in 2012. Investments in the quality of medical care"
steht unter der journalistisch-redaktionellen Verantwortung von

Asklepios Kliniken GmbH (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Asklepios Kliniken GmbH



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z